GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Tuesday reported a loss of $283.1 million in its second quarter.
On a per-share basis, the Gaithersburg, Maryland-based company said it had a loss of $5.38. Losses, adjusted for non-recurring costs, were $2.32 per share.
The biopharmaceutical company posted revenue of $254.7 million in the period.
Emergent Biosolutions expects full-year revenue in the range of $1.05 billion to $1.13 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EBS at https://www.zacks.com/ap/EBS
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
